Skip to main content

Advertisement

Table 2 Spearman correlation analysis between clinicopathological features and AGBL2

From: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer

Clinicopathological features AGBL2 expression (P; Spearman correlation)
Age 0.076 (0.071)
Tumor size 0.053 (0.083)
Clinical stage 0.007 (0.157)
Histological stage 0.036 (0.121)
Lymph node metastasis 0.001 (0.184)
Her2 status 0.086 (0.036)